2019

1. The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors

   Molecules (Basel, Switzerland), Vol. 24, Núm. 23